MyAverix Finance
F · Healthcare
LIQUIDIA CORP. DL-001 (LT4)
Drug Manufacturers - Specialty & Generic
LIQUIDIA CORP. DL-001 (LT4) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-30, reported market cap is $2.78B, P/E ratio is 18.00, net margin is -43.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LT4
LIQUIDIA CORP. DL-001 (LT4) — FAQ
What is LIQUIDIA CORP. DL-001's market cap?
LIQUIDIA CORP. DL-001 (LT4) has a reported market cap of $2.78B (data as of 2026-03-30).
What is LT4's P/E ratio?
The price-to-earnings (P/E) ratio for LIQUIDIA CORP. DL-001 (LT4) is 18.00 (data as of 2026-03-30).
Does LIQUIDIA CORP. DL-001 pay a dividend?
Dividend yield is not available in the current snapshot for LIQUIDIA CORP. DL-001 (LT4). Check the MyAverix Finance app for the latest dividend data.
What sector is LIQUIDIA CORP. DL-001 in?
LIQUIDIA CORP. DL-001 (LT4) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is LT4 listed on?
LT4 is listed on F.
What is LIQUIDIA CORP. DL-001's net margin?
LIQUIDIA CORP. DL-001 (LT4) reports a net margin of -43.5% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.